scispace - formally typeset
P

Paul Thomas

Researcher at University of Queensland

Publications -  35
Citations -  1611

Paul Thomas is an academic researcher from University of Queensland. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 12, co-authored 35 publications receiving 826 citations. Previous affiliations of Paul Thomas include Queensland Health & Royal Brisbane and Women's Hospital.

Papers
More filters
Journal ArticleDOI

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

TL;DR: PSMA PET-CT is a suitable replacement for conventional imaging, providing superior accuracy, to the combined findings of CT and bone scanning, andSubgroup analyses showed the superiority of PSMAPET-CT (area under the curve of the receiver operating characteristic curve 91% vs 59% [32% absolute difference; 28-35] for patients with pelvic nodal metastases, and 95% vs 74% [22%absolute difference; 18-26] for Patients with distant metastases).
Journal ArticleDOI

Pilot study: use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumour.

TL;DR: In this paper, the diagnostic potential of a gallium-68 (68Ga) prostate-specific membrane antigen (PSMA)-binding ligand and positron emission tomography (PET) in detecting metastatic lesions in patients with renal tumour was evaluated.
Journal ArticleDOI

Rectal Carcinoma on 68Ga-PSMA PET/CT.

TL;DR: This case adds to the growing number of observational reports on the presence of significant nonprostatic prostate-specific membrane antigen activity in malignant tumors and highlights the need for careful interpretation of unsuspected sites.
Journal ArticleDOI

Correlation of MRI-derived apparent diffusion coefficients in newly diagnosed gliomas with [18F]-fluoro-L-dopa PET: what are we really measuring with minimum ADC?

TL;DR: There was a poor correlation between minimum ADC and the most viable/aggressive component of high-grade gliomas, and this study suggests that other factors, such as tissue compression and ischemia, may be contributing to restricted diffusion in GBM.